Clinical trial
EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
NCT01119261 is registered in ClinicalTrials.gov with Utrecht Institute for Pharmaceutical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
- Lead sponsor
- Utrecht Institute for Pharmaceutical Sciences
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2010
- Completion date
- June 30, 2013
- Enrollment
- 970 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.